Last Action | 03/17/20: recommitted to Appropriations & Revenue (H) |
---|---|
Title | AN ACT relating to treatment for Lyme disease. |
Bill Documents | Introduced |
Fiscal Impact Statements |
Health Mandate
Additional Fiscal Impact Statements Exist |
Bill Request Number | 1512 |
Sponsors | S. Sheldon, D. Bentley, K. King, C. McCoy |
Summary of Original Version | Create a new section of KRS Chapter 311 to permit a physician to provide long-term antibiotic therapy for a therapeutic purpose for a patient diagnosed with Lyme disease and not be subject to punishment by the State Board of Medical Licensure; require written information on laboratory testing for Lyme disease to be provided when a test is ordered; exempt physicians from civil liability for providing information; create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plan coverage of long-term antibiotic therapy for covered persons with Lyme disease under certain circumstances; EFFECTIVE January 1, 2021. |
Index Headings of Original Version |
Diseases - Long-term antibiotic therapy, Lyme disease, coverage of Drugs and Medicines - Long-term antibiotic therapy, Lyme disease Effective Dates, Delayed - Long-term antibiotic therapy, Lyme disease, coverage of, January 1, 2021 Health and Medical Services - Long-term antibiotic therapy, Lyme disease Insurance, Health - Long-term antibiotic therapy, Lyme disease, coverage of Physicians and Practitioners - Long-term antibiotic therapy, Lyme disease Public Health - Long-term antibiotic therapy, Lyme disease Health Benefit Mandate - Long-term antibiotic therapy, Lyme disease, coverage of Boards and Commissions - Long-term antibiotic therapy, Lyme disease Health Benefit Mandate - Long-term antibiotic therapy, Lyme disease |
Jump to Proposed Amendments | House Committee Substitute 1 with Fiscal Impact Statements |
02/18/20 |
|
---|---|
02/20/20 |
|
03/10/20 |
|
03/12/20 |
|
03/17/20 |
|
Amendment | House Committee Substitute 1 |
---|---|
Fiscal Impact Statement | Fiscal Note to House Committee Substitute 1 |
Summary | Retain original provisions; amend the language relating to physician immunity from civil liability. |
Index Headings |
Public Health - Long-term antibiotic therapy, Lyme disease Boards and Commissions - Long-term antibiotic therapy, Lyme disease Fiscal Note - Long-term antibiotic therapy, Lyme disease Diseases - Long-term antibiotic therapy, Lyme disease, coverage of Drugs and Medicines - Long-term antibiotic therapy, Lyme disease Effective Dates, Delayed - Long-term antibiotic therapy, Lyme disease, coverage of, January 1, 2021 Health and Medical Services - Long-term antibiotic therapy, Lyme disease Insurance, Health - Long-term antibiotic therapy, Lyme disease, coverage of Physicians and Practitioners - Long-term antibiotic therapy, Lyme disease |
Last updated: 10/27/2020 12:10 PM (EDT)
To receive notice when the record is updated follow @LRCTweetBot. @LRCTweetBot